Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

Case Medical Research ◽

10.31525/ct1-nct04133012 ◽

2019 ◽

Author(s):

Keyword(s):

Reverse Transcriptase ◽

Line Treatment ◽

Reverse Transcriptase Inhibitors ◽

Chronic Patients ◽

Hiv 1 ◽

First Line Treatment

Download Full-text

Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkp412 ◽

2009 ◽

Vol 65 (1) ◽

pp. 118-124 ◽

Author(s):

D. Germanaud ◽

A. Derache ◽

M. Traore ◽

Y. Madec ◽

S. Toure ◽

...

Keyword(s):

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Line Treatment ◽

Antiretroviral Resistance ◽

Reverse Transcriptase Inhibitor ◽

Hiv 1 ◽

First Line Treatment

Download Full-text

HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients

Diagnostic Pathology ◽

10.1186/1746-1596-7-138 ◽

2012 ◽

Vol 7 (1) ◽

Author(s):

Aden Elmi Abar ◽

Asma Jlizi ◽

Houssein Youssouf Darar ◽

Mohamed Ali Ben Hadj Kacem ◽

Amine Slim

Keyword(s):

Drug Resistance ◽

Antiretroviral Therapy ◽

Line Treatment ◽

Drug Resistance Genotyping ◽

Hiv 1 ◽

First Line Treatment

Download Full-text

Cost-Effectiveness of Dolutegravir as a First-Line Treatment Option in the HIV-1–Infected Treatment-Naive Patients in Russia

Value in Health Regional Issues ◽

10.1016/j.vhri.2018.08.001 ◽

2018 ◽

Vol 16 ◽

pp. 74-80 ◽

Author(s):

Gabriel Tremblay ◽

Vasiliki Chounta ◽

James Piercy ◽

Tim Holbrook ◽

Shan Ashton Garib ◽

...

Keyword(s):

Cost Effectiveness ◽

Treatment Option ◽

Line Treatment ◽

Treatment Naïve ◽

Hiv 1 ◽

First Line Treatment

Download Full-text

Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitor

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dky211 ◽

2018 ◽

Vol 73 (9) ◽

pp. 2480-2484 ◽

Author(s):

C Spertilli Raffaelli ◽

B Rossetti ◽

L Paglicci ◽

M Colafigli ◽

G Punzi ◽

...

Keyword(s):

Drug Resistance ◽

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Integrase Inhibitor ◽

Reverse Transcriptase Inhibitors ◽

Download Full-text

Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States

Journal of Medical Economics ◽

10.3111/13696998.2015.1046878 ◽

2015 ◽

Vol 18 (10) ◽

pp. 763-776 ◽

Author(s):

Siyang Peng ◽

Ali Tafazzoli ◽

Emily Dorman ◽

Lisa Rosenblatt ◽

Angelina Villasis-Keever ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

The United States ◽

Line Treatment ◽

Hiv 1 ◽

First Line Treatment

Download Full-text

Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

HIV Medicine ◽

10.1111/hiv.12044 ◽

2013 ◽

Vol 14 (9) ◽

pp. 571-577 ◽

Author(s):

MM Santoro ◽

C Sabin ◽

F Forbici ◽

L Bansi ◽

D Dunn ◽

...

Keyword(s):

Drug Resistance ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Reverse Transcriptase Inhibitors ◽

Resistance Development ◽

Nonnucleoside Reverse Transcriptase Inhibitors ◽

Download Full-text

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study

PLoS ONE ◽

10.1371/journal.pone.0095956 ◽

2014 ◽

Vol 9 (5) ◽

pp. e95956 ◽

Author(s):

Fabia zu Knyphausen ◽

Ramona Scheufele ◽

Claudia Kücherer ◽

Klaus Jansen ◽

Sybille Somogyi ◽

...

Keyword(s):

Drug Resistance ◽

Hiv Infection ◽

Treatment Response ◽

Line Treatment ◽

Hiv Drug Resistance ◽

Hiv 1 ◽

First Line Treatment ◽

Download Full-text

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study

10.1016/s0140-6736(13)61164-2 ◽

2013 ◽

Vol 381 (9883) ◽

pp. 2091-2099 ◽

Keyword(s):

Reverse Transcriptase ◽

Virological Failure ◽

Second Line ◽

Reverse Transcriptase Inhibitors ◽

Download Full-text

A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION

International Research Journal of Pharmacy ◽

10.7897/2230-8407.09575 ◽

2018 ◽

Vol 9 (5) ◽

pp. 65-74 ◽

Author(s):

Varaprasad Jagadabi ◽

P V Nagendra Kumar ◽

Srinivasu Pamidi ◽

Lanka A Ramaprasad ◽

D Nagaraju

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Hplc Method ◽

Fixed Dose Combination ◽

Line Treatment ◽

Dose Combination ◽

Hiv 1 ◽

First Line Treatment

Download Full-text

Triple therapy with zidovudine, lamivudine and tenofovir disoproxil fumarate shows efficacy in the first-line treatment of patients with HIV-1 infections,

Inpharma Weekly ◽

10.2165/00128413-200615630-00031 ◽

2006 ◽

Vol &NA; (1563) ◽

pp. 10

Author(s):

&NA;

Keyword(s):

Triple Therapy ◽

Tenofovir Disoproxil Fumarate ◽

Line Treatment ◽

Hiv 1 ◽

First Line Treatment

Download Full-text